Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome

New England Journal of Medicine

Volumn 337, Issue 1, 1997, Pages 15-21

  Van Der Horst, Charles M ^a,k   Saag, Michael S ^b   Cloud, Gretchen A ^b   Hamill, Richard J ^c   Graybill, J R ^d   Sobel, Jack D ^e   Johnson, Philip C ^f   Tuazon, Carmelita U ^g   Kerkering, Thomas ^h   Moskovitz, Bruce L ⁱ   Powderly, William G ^j   Dismukes, William E ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

^h VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^j WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF NORTH CAROLINA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEMALE; FUNGAL MENINGITIS; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; INTRACRANIAL PRESSURE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTIFUNGAL AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FLUCONAZOLE; FLUCYTOSINE; HUMANS; ITRACONAZOLE; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; SURVIVAL ANALYSIS;

EID: 0038025895     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199707033370103     Document Type: Article

References (19)

1. Powderly WG. Cryptococcal meningitis and AIDS. Clin Infect Dis 1993;17:837-42.
2. Bennett JE, Dismukes WE, Duma RJ, et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 1979;301:126-31.
3. Dismukes WE, Cloud G, Gallis HA, et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med 1987;317:334-41.
4. Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989;321:794-9.
5. Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992;326:83-9.
6. Larsen RA, Bozzette SA, Jones BE, et al. Fluconazole combined with flucytosine for treatment of cryptococcal meningitis m patients with AIDS. Clin Infect Dis 1994;19:741-5.
7. de Gans J, Portegies P, Tiessens G, et al. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. AIDS 1992;6:185-90.
8. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
9. Blackwelder WC. "Proving the null hypothesis" in clinical trials. Control Clin Trials 1982;3:345-53.
10. Snedecor GW, Cochran WG. Statistical methods. 6th ed. Ames: Iowa State University Press, 1967.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
12. Hosmer DW Jr, Lemeshow S. Applied logistic regression. New York: John Wiley, 1989.
13. Medoff G, Comfort M, Kobayashi GS. Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms. Proc Soc Exp Biol Med 1971;138:571-4.
14. Block ER, Bennett JE. The combined effect of 5-fluorocytosine and amphotericin B in the therapy of murine cryptococcosis. Proc Soc Exp Biol Med 1973;142:476-80.
15. Larsen RA, Leal MAE, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS: a randomized trial. Ann Intern Med 1990;113:183-7.
16. Saag MS, Cloud GA, Graybill JR, et al. Comparison of fluconazole versus itraconazole as maintenance therapy of AIDS-associated cryptococcal meningitis. In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco September 17-20, 1995. Washington, D.C.: American Society for Microbiology, 1995.
17. Moskovitz BL, Wiesinger B, Cryptococcal Meningitis Research Group. Randomized, comparative study of itraconazole and fluconazole for treatment of AIDS-related cryptococcal meningitis. In: Proceedings of the First National Conference on Human Retroviruses and Related Infections, Washington D.C., December 12-16, 1993. abstract.
18. de Lalla F, Pellizzer G, Vaglia A, et al. Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short period. Clin Infect Dis 1995;20: 263-6.
19. Denning DW, Armstrong RW, Lewis BH, Stevens DA. Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med 1991;91:267-72.